Oncology

Latest News

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com
Making Reflexive Testing the Standard of Care in Lung Cancer: Robert Kratzke, MD

July 22nd 2025

There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or immunohistochemistry, Robert Kratzke, MD, says.

Cancer diagnosis financial strain | Image Credit: Maggie-sort.chatgpt.com
Cancer Diagnoses Bring Major Financial Burden for Privately Insured Adults

July 21st 2025

COVID-19 vaccine for patients with cancer. | Image Credit: Framestock - stock.adobe.com
COVID-19 Boosters Crucial for Patients With Cancer Despite Low Uptake

July 17th 2025

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

July 15th 2025

The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com
Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

July 9th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 22nd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 22nd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Palliative Care Planning
June 10th 2015

Palliative Care Planning

Palliative Care Costs
June 10th 2015

Palliative Care Costs

Issues in Promoting Early Palliative Care
June 10th 2015

Issues in Promoting Early Palliative Care

Site Logo
June 8th 2015

Preventing Anthracycline-Related Late Cardiac Effects in Childhood Cancer Survivors

Vivian I. Franco, MPH Steven E. Lipshultz, MD
In the United States, where 1 in 680 people between 20 and 50 years old are survivors of childhood cancer, the impact of long-term health consequences is a cause for concern, and even more so because this population is increasing.
This Week in Managed Care: June 6, 2015
June 5th 2015

This Week in Managed Care: June 6, 2015

This week CMS released their third round of annual data, the value-based topics of the American Society of Clinical Oncology gained new ground, and The American Journal of Managed Care will travel to their 75th session of the American Diabetes Association in Boston.
Site Logo
June 5th 2015

Drop-off in Prostate Screening Stirs Controversy

Mary K. Caffrey
Data represented May 18, 2015, at the American Urological Association annual meeting in New Orleans, certainly grabbed headlines.
Site Logo
June 5th 2015

IMS Health Report Estimates $100-Billion Global Cancer Spend in 2014

Surabhi Dangi-Garimella, PhD
The report found a 6.5% increase in the compound annual growth rate during the 5-year period leading up to 2014.
Site Logo
June 5th 2015

Nivolumab Assigned Priority Review for First-Line in Melanoma

Surabhi Dangi-Garimella, PhD
BMS has submitted phase 3 results from the CheckMate-066 trial, comparing nivolumab with dacarbazine in treatment-naïve advanced melanoma patients.
Site Logo
June 5th 2015

Cardio-Oncology: A Sign of How Far We Have Come

Joseph Alvarnas, MD
Evidence-Based Oncology's editor in chief introduces the special issue on cardio-oncology.
Site Logo
June 5th 2015

Zarxio Yet to See Light of Day in US Market

Surabhi Dangi-Garimella, PhD
A US appeals court has blocked Novartis from selling the first biosimilar to be approved in the United States.
Site Logo
June 4th 2015

The Biosimilar War Is Not Over Yet

Will Sandoz' biosimilar, first ever in the US, ever see the light of day?
Site Logo
June 4th 2015

21st Century Cures: One Step Forward and Two Back?

Surabhi Dangi-Garimella, PhD
While the 21st Century Cures Act that was recently approved is full of promise for healthcare innovation, experts warn against some of the Act's provisions.
Site Logo
June 3rd 2015

Session on Cardio-oncology Reflects Growing Number of Survivors

Mary Caffrey
A session at the 64th Annual Scientific Session of the American College of Cardiology evaluated the cardiotoxic outcomes of treatment in cancer survivors.
Site Logo
June 3rd 2015

20 Years of Creating and Embracing Guidelines in Cancer Care

Laura Joszt, MA
On the first day of the NCCN 20th Annual Conference in Hollywood, Florida, March 12-14, 2015, panelists took a look back at the last 20 years of the NCCN and why it succeeded when others had failed before.
Site Logo
June 3rd 2015

Defining Value in Cancer Care Treatment

Laura Joszt, MA
Participants on the second day of the National Comprehensive Cancer Network 20th Annual Conference in Hollywood, Florida, March 12-14, 2015, spent a long time defining value in cancer care and how it can be incorporated into healthcare decision making.
Site Logo
June 3rd 2015

Augmenting the Immune System to Achieve Great Outcomes in Cancer Care

Laura Joszt, MA
During the session "Principles of Immunotherapy" at the National Comprehensive Cancer Network 20th Annual Conference in Hollywood, Florida, Anthony J. Olszanski, RPh, MD, from the Fox Chase Cancer Center, described the complex interplay between the immune system and cancer.
Site Logo
June 2nd 2015

To Test for PD-L1 or Not: the Jury's Still Out

Biomarker-directed regimens in cancer not only ensure treatment for the right patient population, it also makes economic sense, especially in today's climate of high-cost specialty medications like the novel immunooncology agents, nivolumab and pembrolizumab.
Site Logo
June 2nd 2015

In Conversation With a Cardiologist: Anju Nohria, MD

Surabhi Dangi-Garimella, PhD
Anju Nohria, MD, assistant professor, Harvard Medical School, spoke to Evidence-Based Oncology about some of the challenges clinicians face with monitoring cardiovascular risks in cancer patients.
Site Logo
June 2nd 2015

Advancing Patient Care in Cardio-Oncology: The ACC.15 Cardio-Oncology Intensive

Tochi M. Okwuosa, DO Ana Barac, MD, PhD
A Cardio-Oncology Working Group formed by the ACC conducted a nationwide survey focused on cardio-oncology services, gathering opinions from cardiovascular division chiefs and fellowship training directors. This helped identify important challenges, including the need for broader educational opportunities and training.
Site Logo
June 2nd 2015

Experts Discuss Medicare's New Oncology Care Model

Surabhi Dangi-Garimella, PhD
The American Journal of Managed Care convened experts in health policy, from health plans, and from community oncology, to discuss OCM and other issues in oncology care during the Oncology Stakeholders Summit, Spring 2015 Peer Exchange.
Site Logo
June 2nd 2015

Value of Patient-Reported Outcomes in Oncology Care

Surabhi Dangi-Garimella, PhD
To discuss patient-reported outcomes and their importance in patient-centered care, The American Journal of Managed Care convened a panel of healthcare experts to participate in the Oncology Stakeholders Summit, Spring 2015 Peer Exchange.
Dr Luis A. Diaz Foresees Mismatched Repair Testing Implementation in Cancer Treatment
June 1st 2015

Dr Luis A. Diaz Foresees Mismatched Repair Testing Implementation in Cancer Treatment

Luis A. Diaz, Jr, MD, associate professor of oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, discovered that patients with high mutational burden with mismatched repair responded well to checkpoint inhibition of PD1.
Site Logo
June 1st 2015

Novel Options in Melanoma and Multiple Myeloma

Surabhi Dangi-Garimella, PhD
Much-anticipated trial results were presented on the third day of the annual meeting of the American Society of Clinical Oncology, held in Chicago. These included phase 3 results from the CheckMate 067 trial and a phase 2 study with elotuzumab.
Site Logo
June 1st 2015

Stakeholder Definition of Value in Cancer: Where Are We 1 Year on?

Surabhi Dangi-Garimella, PhD
While the clinical data presented at the annual meeting of the American Society of Clinical Oncology (ASCO) created waves, a session on value had an equally significant impact as oncologists thronged to hear stakeholder voices define this, as yet abstract, concept of "value" in cancer care. The session brought together a patient representative, an oncologist, an ASCO representative, and a payer.
Dr Alan Balch Shares How PAF Helps Shoulder the Burden of Their Disease
June 1st 2015

Dr Alan Balch Shares How PAF Helps Shoulder the Burden of Their Disease

The Patient Advocate Program (PAF) serves patients with chronic, life threatening or debilitating diseases by providing direct financial support as well as case management support. Alan Balch, PhD, chief executive officer, PAF, explained that PAF guides their members through insurance systems when issues of access or affordability arise for the individual.
Site Logo
May 31st 2015

Predictive Biomarkers Present Promise in Immuno-Oncology

Surabhi Dangi-Garimella, PhD
A late-breaking abstract session early on the second day of the annual meeting of the American Society of Clinical Oncology was reserved for the latest data from clinical trials evaluating the new immuno-oncology agents of the PD-1 inhibitor class.
Dr Peter P. Yu on Supporting Shared Decision Making
May 31st 2015

Dr Peter P. Yu on Supporting Shared Decision Making

Supporting shared decision making between cancer patients and oncologists starts with an understanding of what the physician's role is, explained Peter P. Yu, MD, FACP, FASCP, president of the American Society of Clinical Oncology and director of cancer research at Palo Alto Medical Foundation.
Site Logo
May 31st 2015

Oncologists Evaluate Costs and Patient Barriers to Cancer Care

Surabhi Dangi-Garimella, PhD
During the Health Services Research and Quality of Care session on the second day of the annual meeting of the American Society of Clinical Oncology, being held at the McCormick Convention Center, Chicago, oncologists discussed barriers to patient participation in cancer clinical trials, and discussed attributes of the high cost of care.
Dr John C. Morris Highlights Exciting Developments in Lung Cancer Immunotherapy
May 31st 2015

Dr John C. Morris Highlights Exciting Developments in Lung Cancer Immunotherapy

The introduction of the immune regulatory checkpoint inhibitors and their impressive results is what John C. Morris, MD, professor of hematology and oncology at the University of Cincinnati, finds most exciting in the area of lung cancer immunotherapy.
This Week in Managed Care: May 30, 2015
May 30th 2015

This Week in Managed Care: May 30, 2015

This week CMS unveiled its proposed rule to overhaul Medicaid managed care and folded to Florida Governor Rick Scott, and the American Society of Clinical Oncology kicks off its annual meeting in Chicago.
<1
...
128129130131132133134135136
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo